Cargando…

A novel age-biomarker-clinical history prognostic index for heart failure with reduced left ventricular ejection fraction

PURPOSE: A model for predicting the prognosis of patients with heart failure with reduced left ventricular ejection fraction (HFrEF) is currently not available. This study aimed to develop an age-biomarker-clinical history prognostic index (ABC-PI) and validate it for the assessment of individual pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hao, Cui, Yuan, Tian, Jin, Yang, Hong, Zhang, Qing, Wang, Ke, Han, Qinghua, Zhang, Yanbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712124/ https://www.ncbi.nlm.nih.gov/pubmed/33336021 http://dx.doi.org/10.1515/med-2020-0209

Ejemplares similares

Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction
por: Yoshihisa, Akiomi, et al.
Publicado: (2020)

Prognostic implications of left ventricular ejection fraction trajectory changes in heart failure
por: Ding, Zijie, et al.
Publicado: (2023)

Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis
por: Zhang, Xinxin, et al.
Publicado: (2021)

Prognostic Implications of Changes in Left Ventricular Ejection Fraction and Pulmonary Hypertension in Patients with Heart Failure with Reduced Ejection Fraction
por: Kim, Hyun-Jin
Publicado: (2019)

Prognostic significance of polyvascular disease in heart failure with preserved left ventricular ejection fraction
por: Fujisue, Koichiro, et al.
Publicado: (2019)

Improvement of Left Ventricular Ejection Fraction and Pulmonary Hypertension Are Significant Prognostic Factors in Heart Failure with Reduced Ejection Fraction Patients
por: Kwon, Hee-Jin, et al.
Publicado: (2019)

Characteristics and outcomes of heart failure with recovered left ventricular ejection fraction
por: Zhang, Xinxin, et al.
Publicado: (2021)

HFA-PEFF scores: prognostic value in heart failure with preserved left ventricular ejection fraction
por: Egashira, Koichi, et al.
Publicado: (2022)

Sex differences in patients with heart failure and mildly reduced left ventricular ejection fraction
por: Liu, Zhican, et al.
Publicado: (2023)

Left ventricular volume regulation in heart failure with preserved ejection fraction
por: Kerkhof, Peter L M, et al.
Publicado: (2013)

Left ventricular volume regulation in heart failure with preserved ejection fraction
por: Kerkhof, Peter L M, et al.
Publicado: (2013)

Update of treatment of heart failure with reduction of left ventricular ejection fraction
por: Aronow, Wilbert S.
Publicado: (2016)

Diagnosis and treatment of heart failure with preserved left ventricular ejection fraction
por: Henning, Robert J
Publicado: (2020)

Obesity, Preserved Ejection Fraction Heart Failure, and Left Ventricular Remodeling
por: Stencel, Jason, et al.
Publicado: (2023)

Prognostic Estimation of Advanced Heart Failure With Low Left Ventricular Ejection Fraction and Wide QRS Interval
por: Oh, Changmyung, et al.
Publicado: (2012)

Female Gender Is Associated with an Increased Left Ventricular Ejection Fraction Recovery in Patients with Heart Failure with Reduced Ejection Fraction
por: Kewcharoen, Jakrin, et al.
Publicado: (2022)

Left ventricular geometry transition in hypertensive patients with heart failure with preserved ejection fraction
por: Guan, Ping, et al.
Publicado: (2021)

Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes
por: Filippatos, Gerasimos, et al.
Publicado: (2022)

Left ventricular mass index‐to‐QRS‐voltage ratio predicts outcomes in heart failure with preserved ejection fraction
por: Kinugasa, Yoshiharu, et al.
Publicado: (2022)

Left ventricular contractile performance and heart failure in patients with left ventricular ejection fraction more than 40%
por: Kitada, Shuichi, et al.
Publicado: (2020)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Prognostic impacts of dynamic cardiac structural changes in heart failure patients with preserved left ventricular ejection fraction
por: Yamanaka, Shinsuke, et al.
Publicado: (2020)

Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction
por: Nauta, J. F., et al.
Publicado: (2021)

Vascular Dysfunction Predicts Future Deterioration of Left Ventricular Ejection Fraction in Patients with Heart Failure with Mildly Reduced Ejection Fraction
por: Kishimoto, Shinji, et al.
Publicado: (2021)

Predictors and Outcomes of Heart Failure With Preserved Ejection Fraction in Patients With a Left Ventricular Ejection Fraction Above or Below 60%
por: Nakagawa, Akito, et al.
Publicado: (2022)

High body mass index is a predictor of left ventricular reverse remodelling in heart failure with reduced ejection fraction
por: Cescau, Arthur, et al.
Publicado: (2017)

Heart Failure with Preserved Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction
por: Antonelli, Lucas, et al.
Publicado: (2015)

Cardiac steatosis and left ventricular remodeling in heart failure with reduced and preserved ejection fraction
por: Mahmod, Masliza, et al.
Publicado: (2015)

The clinical significance of plasma neopterin in heart failure with preserved left ventricular ejection fraction
por: Yamamoto, Eiichiro, et al.
Publicado: (2015)

Clinical application of personalized medicine: heart failure with preserved left ventricular ejection fraction
por: Gori, Mauro, et al.
Publicado: (2020)

Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction
por: Butler, Javed, et al.
Publicado: (2021)

Left ventricular fibrosis and hypertrophy are associated with mortality in heart failure with preserved ejection fraction
por: Garg, Pankaj, et al.
Publicado: (2021)

Diabetic Heart Failure with Preserved Left Ventricular Ejection Fraction: Review of Current Pharmacotherapy
por: Benko, Jakub, et al.
Publicado: (2022)

Clinical Study of Heart Failure with Left Ventricular Ejection Fraction Regimen Treated with Entresto
por: Feng, Mingjun, et al.
Publicado: (2022)

Left atrial diameter in heart failure with left ventricular preserved, mid-range, and reduced ejection fraction
por: Zhu, Ning, et al.
Publicado: (2019)

Left atrial strain predicts exercise capacity in heart failure independently of left ventricular ejection fraction
por: Maffeis, Caterina, et al.
Publicado: (2022)

Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction
por: Gehlken, Carolin, et al.
Publicado: (2021)

Incremental Prognostic Significance of the Elevated Levels of Pentraxin 3 in Patients With Heart Failure With Normal Left Ventricular Ejection Fraction
por: Matsubara, Junichi, et al.
Publicado: (2014)

Prognostic significance of brain-derived neurotrophic factor levels in patients with heart failure and reduced left ventricular ejection fraction
por: Barman, Hasan Ali, et al.
Publicado: (2019)

Prognostic Value of Soluble AXL in Serum from Heart Failure Patients with Preserved and Reduced Left Ventricular Ejection Fraction
por: Cristóbal, Helena, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5fk0iujqa6jf5pfl4ar12ps1o7